Lineage Cell Therapeutics (LCTX) Divestments (2018)
Lineage Cell Therapeutics (LCTX) reported Divestments of $3.22 million for FY2018.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Divestments (2018) Analysis & Trends
- Divestments has a three-year compound annual growth rate of 351.2% (FY2015 to FY2018).
- The FY2018 figure ranks as the lowest annual Divestments since FY2015.
- According to Business Quant data, Divestments came in at $4.67 million in FY2016 and $35,000 in FY2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 87.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 1.88 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | - |
API Access
Lineage Cell Therapeutics Divestments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=divestments&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "divestments", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=divestments&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();